Effectiveness of Traditional Chinese Medicine for Liver Protection and Chemotherapy Completion among Cancer Patients
Open Access
- 1 January 2011
- journal article
- website
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2011 (1) , 291843
Abstract
While traditional Chinese medicine (TCM) is widely used among Chinese patients with cancer, studies evaluating the effectiveness of TCM using objective indicators are rare. We examined the effectiveness of TCM for liver protection and completion of chemotherapy among patients with cancer receiving chemotherapy. We used a case‐control design to examine the medical records of patients with cancer who received chemotherapy in a teaching hospital in Taipei in 2004. A total of 184 courses of chemotherapy among 89 patients were studied. Of the 184 courses, 42 used TCM jointly with chemotherapy served as cases, while the remaining 142 courses served as controls. Outcome variables included counts of cancelled or delayed chemotherapies and liver function (aspartate aminotransferase, AST and alanine aminotransferase, ALT) 1 week before, during and 2 weeks after chemotherapy. Generalized estimating equations were used to analyze the data. Patients who had concomitant TCM with chemotherapy had lower serum ALT and AST during chemotherapy than the controls given that the age, sex, cancer stage, radiotherapy sites, cancer diagnosis and potential hepatotoxicity of the chemotherapeutic drugs were controlled for in the model [β = −3.48, 95% confidence interval (CI) −10.08 to 3.11 for AST; β = −5.95, 95% CI: −11.47 to −0.44 for ALT]. There was no significant difference between the case and control groups for odds of completing one course of chemotherapy. Use of TCM with chemotherapy resulted in protection of the liver during chemotherapy, as manifested by lower serum AST and ALT levels.Keywords
Funding Information
- Department of Health, Taiwan (CCMP98-RD-034)
This publication has 21 references indexed in Scilit:
- Use of Complementary and Alternative Medicine Among Patients with Cancer Receiving Outpatient Chemotherapy in TaiwanThe Journal of Alternative and Complementary Medicine, 2008
- Antituberculosis drug‐induced hepatotoxicity: Concise up‐to‐date reviewJournal of Gastroenterology and Hepatology, 2007
- Antioxidant Activity of 45 Chinese Herbs and the Relationship with their TCM CharacteristicsEvidence-Based Complementary and Alternative Medicine, 2007
- Dose Individualization of Carboplatin After a 120-hour Infusion Schedule: Higher Dose Intensity but Fewer ToxicitiesTherapeutic Drug Monitoring, 2006
- Hepatotoxicity of ChemotherapySeminars in Oncology, 2006
- Hepatotoxicity of antiretrovirals: Incidence, mechanisms and managementJournal of Hepatology, 2006
- Types of Alternative Medicine Used by Patients with Breast, Colon, or Prostate Cancer: Predictors, Motives, and CostsThe Journal of Alternative and Complementary Medicine, 2002
- Mechanisms of HepatotoxicityToxicological Sciences, 2002
- Hepatoprotective Activity of Licorice Water Extract against Cadmium‐Induced Toxicity in RatsEvidence-Based Complementary and Alternative Medicine, 2000
- Cross sectional study of use of alternative medicines in Chinese cancer patientsJapanese Journal of Clinical Oncology, 1997